RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. Series A USD 71,000,000

BEST FUNDED


Biotechnology company focused on oncology and autoimmune disorders.